Drug Maker’s Suit Against Kentucky Regulator Over Investigation Is Speculative
CINCINNATI — A federal district court did not err in dismissing a biopharmaceutical company’s lawsuit against the Kentucky Public Protection Cabinet’s Department of Financial Institutions (DFI) on ripeness grounds because the...To view the full article, register now.
Already a subscriber? Click here to view full article